Drug Toxicity Testing

Drug Toxicity Testing is a scientific methodology within preclinical drug development that employs in vitro models, particularly organ-on-chip systems, to assess the adverse effects of pharmaceutical compounds on human physiological functions, thereby differentiating it from efficacy-focused or in silico screening approaches.

752

Publications

41.7K

Citations

3.7K

Authors

1.2K

Institutions

Publications per year

2017–2026

149

Authors

3.7K

  1. BE
    Björn Ekwall

    Uppsala University, Sweden

    5 publications · 165 citations

    5

    h-index

  2. NG
    Nigel Greene

    Pfizer (United States), United States

    5 publications · 1.1K citations

    5

    h-index

  3. AP
    Albert P. Li

    In Vitro Admet Laboratories (United States), United States

    5 publications · 307 citations

    5

    h-index

  4. LK
    Laura K. Schnackenberg

    National Center for Toxicological Research, United States

    4 publications · 139 citations

    4

    h-index

  5. TH
    Thomas Härtung

    University of Konstanz, Germany

    4 publications · 151 citations

    4

    h-index

1–5 of 3.7K

Venues

  1. PubMed

    Repository · 74 publications · 2.9K citations

    32

    h-index

  2. Toxicology in Vitro

    19 publications · 956 citations

    16

    h-index

  3. Regulatory Toxicology and Pharmacology

    RTP · 17 publications · 754 citations

    16

    h-index

  4. Scientific Reports

    12 publications · 1.1K citations

    12

    h-index

  5. Alternatives to Laboratory Animals

    11 publications · 432 citations

    11

    h-index

1–5